# EDGAR Filing Document

**Accession Number:** 0001931118
**File Stem:** 0001931118-25-000007
**Filing Date:** 2025-8
**Character Count:** 74919
**Document Hash:** 839a60a42e952e1f81457ae9c6ab3341
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001931118-25-000007.hdr.sgml**: 20250826

**ACCESSION NUMBER**: 0001931118-25-000007

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250826

**EFFECTIVENESS DATE**: 20250826

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SUPERSTRING CAPITAL MANAGEMENT LP
- **CENTRAL INDEX KEY:** 0001931118

**ORGANIZATION NAME:**
- **EIN:** 842294278
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-23866
- **FILM NUMBER:** 251255841

**BUSINESS ADDRESS:**
- **STREET 1:** 150 E. 52ND ST
- **STREET 2:** SUITE 5004
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 212-257-5690

**MAIL ADDRESS:**
- **STREET 1:** 150 E. 52ND ST
- **STREET 2:** SUITE 5004
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001931118

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** SUPERSTRING CAPITAL MANAGEMENT LP

**Address:** 150 E. 52ND ST, NEW YORK, NY 10022

**Telephone number:** 212-257-5690

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-23866

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER              | CUSIP   | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| PYXIS ONCOLOGY, INC.        |  | 10/23/2024     | Approval of an increase in the number of shares of our common stock available for issuance under our 2021 Equity and Incentive Plan by 5,500,000 shares.                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |              1 |                0 | FOR         |                                        1 | FOR                         |  |
| PYXIS ONCOLOGY, INC.        |  | 10/23/2024     | Approval of an increase in the number of shares of our common stock available for issuance under our 2021 Equity and Incentive Plan by 5,500,000 shares.                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |             22 |                0 | FOR         |                                       22 | FOR                         |  |
| ASCLETIS PHARMA INC.        |  | 02/03/2025     | TO CONSIDER AND APPROVE THE PROPOSALS FOR THE ADOPTION OF 2025 SHARE OPTION SCHEME AND THE 2025 SHARE AWARD SCHEME,AS WELL AS THE TERMINATION OF THE EXISTING SHARE OPTION SCHEME, AND AUTHORISE THE DIRECTORS OF THE COMPANY (THE "DIRECTORS") TO GRANT THE OPTIONS IN ACCORDANCE WITH THE 2025 SHARE OPTION SCHEME AND GRANT THE SHARE AWARDS IN ACCORDANCE WITH THE 2025 SHARE AWARD SCHEME, AND TO DO ALL SUCH ACTS AND EXECUTE ALL SUCH DOCUMENTS AS THEY MAY DEEM NECESSARY OR EXPEDIENT TO GIVE FULL EFFECT TO THE 2025 SHARE OPTION SCHEME AND THE 2025 SHARE AWARD SCHEME  | SECTION 14A SAY-ON-PAY VOTES |              0 |           711458 | ABSTAIN     |                                        0 | FOR                         |  |
| ASCLETIS PHARMA INC.        |  | 02/03/2025     | TO CONSIDER AND APPROVE THE SCHEME MANDATE LIMITS OF THE 2025 SHARE OPTION SCHEME AND THE 2025 SHARE AWARD SCHEME                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |              0 |           711458 | ABSTAIN     |                                        0 | FOR                         |  |
| ASCLETIS PHARMA INC.        |  | 02/03/2025     | CONDITIONAL UPON THE 2025 SHARE OPTION SCHEME AND THE 2025 SHARE AWARD SCHEME TAKING EFFECT, TO CONSIDER AND APPROVE THE GRANT OF 14,460,525 OPTIONS TO DR. JASON JINZI WU PURSUANT TO THE 2025 SHARE OPTION SCHEME AND THE GRANT OF 23,136,840 SHARE AWARDS PURSUANT TO THE 2025 SHARE AWARD SCHEME AND TO AUTHORISE DIRECTORS TO DO ALL SUCH ACTS AND/OR EXECUTE ALL SUCH DOCUMENTS AS MAY BE NECESSARY OR EXPEDIENT IN ORDER TO GIVE EFFECT TO THE FOREGOING                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |              0 |           711458 | ABSTAIN     |                                        0 | FOR                         |  |
| ASCLETIS PHARMA INC.        |  | 02/03/2025     | CONDITIONAL UPON THE 2025 SHARE OPTION SCHEME AND THE 2025 SHARE AWARD SCHEME TAKING EFFECT, TO CONSIDER AND APPROVE THE GRANT OF 4,820,175 OPTIONS TO MR. JOHN P. GARGIULO PURSUANT TO THE 2025 SHARE OPTION SCHEME AND THE GRANT OF 5,784,210 SHARE AWARDS PURSUANT TO THE 2025 SHARE AWARD SCHEME AND TO AUTHORISE DIRECTORS TO DO ALL SUCH ACTS AND/OR EXECUTE ALL SUCH DOCUMENTS AS MAY BE NECESSARY OR EXPEDIENT IN ORDER TO GIVE EFFECT TO THE FOREGOING                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |              0 |           711458 | ABSTAIN     |                                        0 | FOR                         |  |
| ASCLETIS PHARMA INC.        |  | 02/03/2025     | CONDITIONAL UPON THE 2025 SHARE OPTION SCHEME AND THE 2025 SHARE AWARD SCHEME TAKING EFFECT, TO CONSIDER AND APPROVE THE GRANT OF 3,856,140 OPTIONS TO MRS. JUDY HEJINGDAO WU PURSUANT TO THE 2025 SHARE OPTION SCHEME AND THE GRANT OF 4,820,175 SHARE AWARDS PURSUANT TO THE 2025 SHARE AWARD SCHEME AND TO AUTHORISE DIRECTORS TO DO ALL SUCH ACTS AND/OR EXECUTE ALL SUCH DOCUMENTS AS MAY BE NECESSARY OR EXPEDIENT IN ORDER TO GIVE EFFECT TO THE FOREGOING                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |              0 |           711458 | ABSTAIN     |                                        0 | FOR                         |  |
| ASCLETIS PHARMA INC.        |  | 02/03/2025     | TO CONSIDER AND APPROVE THE PROPOSALS FOR THE ADOPTION OF 2025 SHARE OPTION SCHEME AND THE 2025 SHARE AWARD SCHEME, AS WELL AS THE TERMINATION OF THE EXISTING SHARE OPTION SCHEME, AND AUTHORISE THE DIRECTORS OF THE COMPANY (THE "DIRECTORS") TO GRANT THE OPTIONS IN ACCORDANCE WITH THE 2025 SHARE OPTION SCHEME AND GRANT THE SHARE AWARDS IN ACCORDANCE WITH THE 2025 SHARE AWARD SCHEME, AND TO DO ALL SUCH ACTS AND EXECUTE ALL SUCH DOCUMENTS AS THEY MAY DEEM NECESSARY OR EXPEDIENT TO GIVE FULL EFFECT TO THE 2025 SHARE OPTION SCHEME AND THE 2025 SHARE AWARD SCHEME | SECTION 14A SAY-ON-PAY VOTES |              0 |            66542 | ABSTAIN     |                                        0 | FOR                         |  |
| ASCLETIS PHARMA INC.        |  | 02/03/2025     | TO CONSIDER AND APPROVE THE SCHEME MANDATE LIMITS OF THE 2025 SHARE OPTION SCHEME AND THE 2025 SHARE AWARD SCHEME                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |              0 |            66542 | ABSTAIN     |                                        0 | FOR                         |  |
| ASCLETIS PHARMA INC.        |  | 02/03/2025     | CONDITIONAL UPON THE 2025 SHARE OPTION SCHEME AND THE 2025 SHARE AWARD SCHEME TAKING EFFECT, TO CONSIDER AND APPROVE THE GRANT OF 14,460,525 OPTIONS TO DR. JASON JINZI WU PURSUANT TO THE 2025 SHARE OPTION SCHEME AND THE GRANT OF 23,136,840 SHARE AWARDS PURSUANT TO THE 2025 SHARE AWARD SCHEME AND TO AUTHORISE DIRECTORS TO DO ALL SUCH ACTS AND/OR EXECUTE ALL SUCH DOCUMENTS AS MAY BE NECESSARY OR EXPEDIENT IN ORDER TO GIVE EFFECT TO THE FOREGOING                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |              0 |            66542 | ABSTAIN     |                                        0 | FOR                         |  |
| ASCLETIS PHARMA INC.        |  | 02/03/2025     | CONDITIONAL UPON THE 2025 SHARE OPTION SCHEME AND THE 2025 SHARE AWARD SCHEME TAKING EFFECT, TO CONSIDER AND APPROVE THE GRANT OF 4,820,175 OPTIONS TO MR. JOHN P. GARGIULO PURSUANT TO THE 2025 SHARE OPTION SCHEME AND THE GRANT OF 5,784,210 SHARE AWARDS PURSUANT TO THE 2025 SHARE AWARD SCHEME AND TO AUTHORISE DIRECTORS TO DO ALL SUCH ACTS AND/OR EXECUTE ALL SUCH DOCUMENTS AS MAY BE NECESSARY OR EXPEDIENT IN ORDER TO GIVE EFFECT TO THE FOREGOING                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |              0 |            66542 | ABSTAIN     |                                        0 | FOR                         |  |
| ASCLETIS PHARMA INC.        |  | 02/03/2025     | CONDITIONAL UPON THE 2025 SHARE OPTION SCHEME AND THE 2025 SHARE AWARD SCHEME TAKING EFFECT, TO CONSIDER AND APPROVE THE GRANT OF 3,856,140 OPTIONS TO MRS. JUDY HEJINGDAO WU PURSUANT TO THE 2025 SHARE OPTION SCHEME AND THE GRANT                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |              0 |            66542 | ABSTAIN     |                                        0 | FOR                         |  |
| PFIZER INC.                 |  | 04/24/2025     | 2025 advisory approval of executive compensation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |            399 |                0 | FOR         |                                      399 | FOR                         |  |
| PFIZER INC.                 |  | 04/24/2025     | Shareholder Vote Regarding Golden Parachutes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |            399 |                0 | AGAINST     |                                      399 | AGAINST                     |  |
| PFIZER INC.                 |  | 04/24/2025     | 2025 advisory approval of executive compensation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |           4071 |                0 | FOR         |                                     4071 | FOR                         |  |
| PFIZER INC.                 |  | 04/24/2025     | Shareholder Vote Regarding Golden Parachutes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |           4071 |                0 | AGAINST     |                                     4071 | AGAINST                     |  |
| VERONA PHARMA PLC           |  | 04/24/2025     | To approve, on an advisory (non- binding) basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |           7376 |                0 | FOR         |                                     7376 | FOR                         |  |
| VERONA PHARMA PLC           |  | 04/24/2025     | To approve, on an advisory (non- binding) basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |          44273 |                0 | FOR         |                                    44273 | FOR                         |  |
| CYTOKINETICS, INCORPORATED  |  | 05/14/2025     | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |             22 |                0 | FOR         |                                       22 | FOR                         |  |
| CYTOKINETICS, INCORPORATED  |  | 05/14/2025     | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |            234 |                0 | FOR         |                                      234 | FOR                         |  |
| TRAVERE THERAPEUTICS, INC.  |  | 05/14/2025     | To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 4,000,000 shares.                                                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         200024 |                0 | FOR         |                                   200024 | FOR                         |  |
| TRAVERE THERAPEUTICS, INC.  |  | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         200024 |                0 | FOR         |                                   200024 | FOR                         |  |
| TRAVERE THERAPEUTICS, INC.  |  | 05/14/2025     | To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 4,000,000 shares.                                                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          19515 |                0 | FOR         |                                    19515 | FOR                         |  |
| TRAVERE THERAPEUTICS, INC.  |  | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          19515 |                0 | FOR         |                                    19515 | FOR                         |  |
| ASCLETIS PHARMA INC.        |  | 05/22/2025     | TO AUTHORIZE THE BOARD OF DIRECTORS TO FIX THE REMUNERATION OF THE DIRECTORS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        3831993 |                0 | FOR         |                                  3831993 | FOR                         |  |
| ASCLETIS PHARMA INC.        |  | 05/22/2025     | TO AUTHORIZE THE BOARD OF DIRECTORS TO FIX THE REMUNERATION OF THE DIRECTORS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         408007 |                0 | FOR         |                                   408007 | FOR                         |  |
| VERASTEM, INC.              |  | 05/22/2025     | To approve an advisory vote on the compensation of the named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |            460 |                0 | FOR         |                                      460 | FOR                         |  |
| VERASTEM, INC.              |  | 05/22/2025     | To approve an advisory vote on the compensation of the named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |           4735 |                0 | FOR         |                                     4735 | FOR                         |  |
| CAPRICOR THERAPEUTICS, INC. |  | 05/22/2025     | APPROVAL OF THE CAPRICOR THERAPEUTICS 2025 EQUITY INCENTIVE PLAN.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |              9 |                0 | FOR         |                                        9 | FOR                         |  |
| CAPRICOR THERAPEUTICS, INC. |  | 05/22/2025     | APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |              9 |                0 | FOR         |                                        9 | FOR                         |  |
| 89BIO, INC.                 |  | 05/28/2025     | Approval of, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |           9712 |                0 | FOR         |                                     9712 | FOR                         |  |
| 89BIO, INC.                 |  | 05/28/2025     | Approval of, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          99444 |                0 | FOR         |                                    99444 | FOR                         |  |
| GENSCRIPT BIOTECH           |  | 05/29/2025     | TO AUTHORIZE THE BOARD OF DIRECTORS (THE BOARD) TO FIX REMUNERATION OF THE DIRECTORS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        4615995 |           426540 | FOR         |                                  4615995 | FOR                         |  |
| CORPORATION                 |  |  |  |  |  |  |  |  |  |  |
| GENSCRIPT BIOTECH           |  | 05/29/2025     | TO AUTHORIZE THE BOARD OF DIRECTORS (THE BOARD) TO FIX REMUNERATION OF THE DIRECTORS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |              0 |           551465 | ABSTAIN     |                                        0 | FOR                         |  |
| CORPORATION                 |  |  |  |  |  |  |  |  |  |  |
| CSPC PHARMACEUTICAL         |  | 05/30/2025     | TO AUTHORISE THE BOARD OF DIRECTORS TO FIX THE REMUNERATION OF DIRECTORS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        2875075 |                0 | FOR         |                                  2875075 | FOR                         |  |
| GROUP LIMITED               |  |  |  |  |  |  |  |  |  |  |
| CSPC PHARMACEUTICAL         |  | 05/30/2025     | TO AUTHORISE THE BOARD OF DIRECTORS TO FIX THE REMUNERATION OF DIRECTORS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         308925 |                0 | FOR         |                                   308925 | FOR                         |  |
| GROUP LIMITED               |  |  |  |  |  |  |  |  |  |  |
| COGENT BIOSCIENCES, INC.    |  | 06/04/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |              1 |                0 | FOR         |                                        1 | FOR                         |  |
| SAVARA INC.                 |  | 06/05/2025     | To approve, on an advisory basis, the compensation of our named executives.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |            564 |                0 | FOR         |                                      564 | FOR                         |  |
| SAVARA INC.                 |  | 06/05/2025     | To approve, on an advisory basis, the compensation of our named executives.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |             55 |                0 | FOR         |                                       55 | FOR                         |  |
| MOONLAKE                    |  | 06/05/2025     | Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |           2850 |                0 | FOR         |                                     2850 | FOR                         |  |
| IMMUNOTHERAPEUTICS          |  |  |  |  |  |  |  |  |  |  |
| MOONLAKE                    |  | 06/05/2025     | Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |            372 |                0 | FOR         |                                      372 | FOR                         |  |
| IMMUNOTHERAPEUTICS          |  |  |  |  |  |  |  |  |  |  |
| TECTONIC THERAPEUTIC, INC   |  | 06/06/2025     | Advisory approval of the compensation of the Company's Named Executive Officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          44588 |                0 | FOR         |                                    44588 | FOR                         |  |
| TECTONIC THERAPEUTIC, INC   |  | 06/06/2025     | Advisory approval of the compensation of the Company's Named Executive Officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |           2583 |                0 | FOR         |                                     2583 | FOR                         |  |
| CABALETTA BIO, INC.         |  | 06/09/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          36022 |                0 | FOR         |                                    36022 | FOR                         |  |
| CABALETTA BIO, INC.         |  | 06/09/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         331959 |                0 | FOR         |                                   331959 | FOR                         |  |
| JACOBIO PHARMACEUTICALS     |  | 06/10/2025     | TO AUTHORIZE THE BOARD (THE BOARD) OF DIRECTORS TO FIX THE REMUNERATION OF THE DIRECTORS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        4945150 |                0 | FOR         |                                  4945150 | FOR                         |  |
| GROUP CO., LTD.             |  |  |  |  |  |  |  |  |  |  |
| JACOBIO PHARMACEUTICALS     |  | 06/10/2025     | TO AUTHORIZE THE BOARD (THE BOARD) OF DIRECTORS TO FIX THE REMUNERATION OF THE DIRECTORS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         513450 |                0 | FOR         |                                   513450 | FOR                         |  |
| GROUP CO., LTD.             |  |  |  |  |  |  |  |  |  |  |
| AVIDITY BIOSCIENCES, INC.   |  | 06/10/2025     | To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |           6625 |                0 | FOR         |                                     6625 | FOR                         |  |
| AVIDITY BIOSCIENCES, INC.   |  | 06/10/2025     | To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          60086 |                0 | FOR         |                                    60086 | FOR                         |  |
| ASYMCHEM LABORATORIES       |  | 06/11/2025     | THE DIRECTORS REMUNERATION FOR THE YEAR 2024 AND PROPOSED REMUNERATION FOR THE YEAR 2025                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         103192 |                0 | FOR         |                                   103192 | FOR                         |  |
| (TIANJIN) CO LTD            |  |  |  |  |  |  |  |  |  |  |
| ASYMCHEM LABORATORIES       |  | 06/11/2025     | THE DIRECTORS REMUNERATION FOR THE YEAR 2024 AND PROPOSED REMUNERATION FOR THE YEAR 2025                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |            436 |            10572 | FOR         |                                      436 | FOR                         |  |
| (TIANJIN) CO LTD            |  |  |  |  |  |  |  |  |  |  |
| CRINETICS PHARMACEUTICALS   |  | 06/11/2025     | To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |             57 |                0 | FOR         |                                       57 | FOR                         |  |
| INC.                        |  |  |  |  |  |  |  |  |  |  |
| CRINETICS PHARMACEUTICALS   |  | 06/11/2025     | To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |            590 |                0 | FOR         |                                      590 | FOR                         |  |
| INC.                        |  |  |  |  |  |  |  |  |  |  |
| OCULAR THERAPEUTIX, INC.    |  | 06/11/2025     | To approve an advisory vote on named executive officer compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |            102 |                0 | FOR         |                                      102 | FOR                         |  |
| OCULAR THERAPEUTIX, INC.    |  | 06/11/2025     | To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 8,750,000 shares.                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |            102 |                0 | FOR         |                                      102 | FOR                         |  |
| OCULAR THERAPEUTIX, INC.    |  | 06/11/2025     | To approve an advisory vote on named executive officer compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |            919 |                0 | FOR         |                                      919 | FOR                         |  |
| OCULAR THERAPEUTIX, INC.    |  | 06/11/2025     | To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 8,750,000 shares.                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |            919 |                0 | FOR         |                                      919 | FOR                         |  |
| ZAI LAB LTD                 |  | 06/18/2025     | THAT, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANYS NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT, IS HEREBY APPROVED                                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         762830 |                0 | FOR         |                                   762830 | FOR                         |  |
| ZAI LAB LTD                 |  | 06/18/2025     | THAT, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANYS NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT, IS HEREBY APPROVED                                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |           9990 |            73580 | FOR         |                                     9990 | FOR                         |  |
| JOINN LABORATORIES (CHINA)  |  | 06/18/2025     | THE PROPOSED REMUNERATION OF DIRECTORS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         455266 |                0 | FOR         |                                   455266 | FOR                         |  |
| CO., LTD.                   |  |  |  |  |  |  |  |  |  |  |
| JOINN LABORATORIES (CHINA)  |  | 06/18/2025     | THE PROPOSED REMUNERATION OF DIRECTORS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          48734 |                0 | FOR         |                                    48734 | FOR                         |  |
| CO., LTD.                   |  |  |  |  |  |  |  |  |  |  |
| ZAI LAB LTD                 |  | 06/18/2025     | An ordinary resolution to approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         257993 |                0 | FOR         |                                   257993 | FOR                         |  |
| ZAI LAB LTD                 |  | 06/18/2025     | An ordinary resolution to approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          35981 |                0 | FOR         |                                    35981 | FOR                         |  |
| PHARMARON BEIJING CO.,      |  | 06/20/2025     | REMUNERATION OF THE DIRECTORS FOR THE YEAR 2025                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         295351 |           300101 | FOR         |                                   295351 | FOR                         |  |
| LTD.                        |  |  |  |  |  |  |  |  |  |  |
| PHARMARON BEIJING CO.,      |  | 06/20/2025     | REMUNERATION OF THE DIRECTORS FOR THE YEAR 2025                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |              0 |            64648 | ABSTAIN     |                                        0 | FOR                         |  |
| LTD.                        |  |  |  |  |  |  |  |  |  |  |
| BRIDGEBIO PHARMA, INC.      |  | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |           1176 |                0 | FOR         |                                     1176 | FOR                         |  |
| BRIDGEBIO PHARMA, INC.      |  | 06/20/2025     | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 5,000,000 shares.                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |           1176 |                0 | FOR         |                                     1176 | FOR                         |  |
| BRIDGEBIO PHARMA, INC.      |  | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          14917 |                0 | FOR         |                                    14917 | FOR                         |  |
| BRIDGEBIO PHARMA, INC.      |  | 06/20/2025     | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of<br>common stock reserved for issuance thereunder by 5,000,000 shares.                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          14917 |                0 | FOR         |                                    14917 | FOR                         |  |
| MADRIGAL PHARMACEUTICALS    |  | 06/20/2025     | Advisory vote to approve executive compensation and approve the frequency of future advisory votes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |             34 |                0 | FOR         |                                       34 | FOR                         |  |
| INC.                        |  |  |  |  |  |  |  |  |  |  |
| MADRIGAL PHARMACEUTICALS    |  | 06/20/2025     | Advisory vote to approve executive compensation and approve the frequency of future advisory votes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |            468 |                0 | FOR         |                                      468 | FOR                         |  |
| INC.                        |  |  |  |  |  |  |  |  |  |  |
| REMEGEN CO. LTD.            |  | 06/26/2025     | TO CONSIDER AND APPROVE THE PROPOSED AMENDMENTS TO THE TERMS OF REFERENCE FOR THE INDEPENDENT DIRECTORS OF THE COMPANY                                                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         577879 |                0 | FOR         |                                   577879 | FOR                         |  |
| REMEGEN CO. LTD.            |  | 06/26/2025     | TO CONSIDER AND CONFIRM THE REMUNERATION OF DIRECTORS OF THE COMPANY                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |              0 |            61621 | ABSTAIN     |                                        0 | FOR                         |  |
| REMEGEN CO. LTD.            |  | 06/26/2025     | TO CONSIDER AND APPROVE THE PROPOSED AMENDMENTS TO THE TERMS OF REFERENCE FOR THE INDEPENDENT DIRECTORS OF THE COMPANY                                                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |              0 |            61621 | ABSTAIN     |                                        0 | FOR                         |  |
| MORIMATSU INTERNATIONAL     |  | 06/26/2025     | TO RE-ELECT MR. NISHIMATSU KOEI AS EXECUTIVE DIRECTOR AND TO AUTHORISE THE BOARD OF DIRECTORS (THE "BOARD") TO FIX HIS REMUNERATION                                                                                                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        2388669 |                0 | FOR         |                                  2388669 | FOR                         |  |
| HOLDINGS COMPANY LIMITED    |  |  |  |  |  |  |  |  |  |  |
| MORIMATSU INTERNATIONAL     |  | 06/26/2025     | TO RE-ELECT MR. TANG WEIHUA AS EXECUTIVE DIRECTOR AND TO AUTHORISE THE BOARD TO FIX HIS REMUNERATION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        2388669 |                0 | FOR         |                                  2388669 | FOR                         |  |
| HOLDINGS COMPANY LIMITED    |  |  |  |  |  |  |  |  |  |  |
| MORIMATSU INTERNATIONAL     |  | 06/26/2025     | TO RE-ELECT MR. SHENG YE AS EXECUTIVE DIRECTOR AND TO AUTHORISE THE BOARD TO FIX HIS REMUNERATION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |        2388669 |                0 | FOR         |                                  2388669 | FOR                         |  |
| HOLDINGS COMPANY LIMITED    |  |  |  |  |  |  |  |  |  |  |
| MORIMATSU INTERNATIONAL     |  | 06/26/2025     | TO AUTHORISE THE BOARD TO FIX THE REMUNERATION OF OTHER DIRECTORS OF THE COMPANY                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        2388669 |                0 | FOR         |                                  2388669 | FOR                         |  |
| HOLDINGS COMPANY LIMITED    |  |  |  |  |  |  |  |  |  |  |
| MORIMATSU INTERNATIONAL     |  | 06/26/2025     | TO RE-ELECT MR. NISHIMATSU KOEI AS EXECUTIVE DIRECTOR AND TO AUTHORISE THE BOARD OF DIRECTORS (THE "BOARD") TO FIX HIS REMUNERATION                                                                                                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          24970 |           228361 | FOR         |                                    24970 | FOR                         |  |
| HOLDINGS COMPANY LIMITED    |  |  |  |  |  |  |  |  |  |  |
| MORIMATSU INTERNATIONAL     |  | 06/26/2025     | TO RE-ELECT MR. TANG WEIHUA AS EXECUTIVE DIRECTOR AND TO AUTHORISE THE BOARD TO FIX HIS REMUNERATION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          24970 |           228361 | FOR         |                                    24970 | FOR                         |  |
| HOLDINGS COMPANY LIMITED    |  |  |  |  |  |  |  |  |  |  |
| MORIMATSU INTERNATIONAL     |  | 06/26/2025     | TO RE-ELECT MR. SHENG YE AS EXECUTIVE DIRECTOR AND TO AUTHORISE THE BOARD TO FIX HIS REMUNERATION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          24970 |           228361 | FOR         |                                    24970 | FOR                         |  |
| HOLDINGS COMPANY LIMITED    |  |  |  |  |  |  |  |  |  |  |
| MORIMATSU INTERNATIONAL     |  | 06/26/2025     | TO AUTHORISE THE BOARD TO FIX THE REMUNERATION OF OTHER DIRECTORS OF THE COMPANY                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          24970 |           228361 | FOR         |                                    24970 | FOR                         |  |
| HOLDINGS COMPANY LIMITED    |  |  |  |  |  |  |  |  |  |  |
| AKESO, INC.                 |  | 06/30/2025     | TO CONSIDER AND APPROVE THE GRANT OF 3,000,000 SHARE OPTIONS UNDER THE SHARE OPTION SCHEME TO DR. XIA                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         269185 |                0 | FOR         |                                   269185 | FOR                         |  |
| AKESO, INC.                 |  | 06/30/2025     | TO CONSIDER AND APPROVE THE GRANT OF 2,000,000 RSUS UNDER THE 2021 RSU SCHEME TO DR. XIA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         269185 |                0 | FOR         |                                   269185 | FOR                         |  |
| AKESO, INC.                 |  | 06/30/2025     | TO CONSIDER AND APPROVE THE GRANT OF 3,000,000 SHARE OPTIONS UNDER THE SHARE OPTION SCHEME TO DR. XIA                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          25569 |             3246 | FOR         |                                    25569 | FOR                         |  |
| AKESO, INC.                 |  | 06/30/2025     | TO CONSIDER AND APPROVE THE GRANT OF 2,000,000 RSUS UNDER THE 2021 RSU SCHEME TO DR. XIA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          25569 |             3246 | FOR         |                                    25569 | FOR                         |  |
| AKESO, INC.                 |  | 06/30/2025     | TO AUTHORIZE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX THE REMUNERATION OF THE DIRECTORS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         269185 |                0 | FOR         |                                   269185 | FOR                         |  |
| AKESO, INC.                 |  | 06/30/2025     | TO AUTHORIZE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX THE REMUNERATION OF THE DIRECTORS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |          25569 |             3246 | FOR         |                                    25569 | FOR                         |  |
| SINOMAB BIOSCIENCE LIMITED  |  | 06/30/2025     | TO AUTHORISE THE BOARD OF DIRECTORS TO FIX THE RESPECTIVE DIRECTORS' REMUNERATION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |        1579942 |                0 | FOR         |                                  1579942 | FOR                         |  |
| SINOMAB BIOSCIENCE LIMITED  |  | 06/30/2025     | TO AUTHORISE THE BOARD OF DIRECTORS TO FIX THE RESPECTIVE DIRECTORS' REMUNERATION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         169058 |                0 | FOR         |                                   169058 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** SUPERSTRING CAPITAL MANAGEMENT LP

**By (Signature):** George Song

**By (Printed Signature):** George Song

**By (Title):** Chief Compliance Officer

**Date:** 08/26/2025